|
ARMP Armata Pharmaceuticals Inc 921114 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-115,346,000.00 |
| Balance Sheet |
|
Current Assets
|
$5,946,000.00 |
|
Assets
|
$69,800,000.00 |
|
Current Liabilities
|
$9,228,000.00 |
|
Liabilities
|
$381,386,000.00 |
|
Equity
|
$-311,586,000.00 |
|
Shares Out
|
36431444.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-5,782,000.00 |
|
Investing Cash Flow
|
$-63,000.00 |
| Market Analysis |
Market Cap
|
$174,142,302.32 |
|
Price
|
$4.79 |
|
PB
|
1.68 |
|
EPS
|
-3.16 |
|
FCF
|
$-5,845,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:33 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:30 |
|
| Apr |
May |
Jun |
| 2026-03-25 |
-3.42 |
|
|
2026-05-13 |
-3.16 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.45 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-0.74 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ARMP documents filed with the SEC.
ARMP Filings
Clear
